Pages that link to "Q27021649"
Jump to navigation
Jump to search
The following pages link to Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS (Q27021649):
Displaying 9 items.
- PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]. (Q38721255) (← links)
- Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor (Q38894826) (← links)
- Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications (Q38991916) (← links)
- PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide (Q42316209) (← links)
- Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide (Q42361109) (← links)
- Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities (Q43197362) (← links)
- RNA Sequencing Reveals Novel Transcripts from Sympathetic Stellate Ganglia During Cardiac Sympathetic Hyperactivity. (Q55290820) (← links)
- Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine. (Q55440030) (← links)
- Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases (Q100635461) (← links)